First report of active renin in rat amniotic fluid

Aphrodite Caragounis, Kathy Koutsis, Mary E. Wlodek, Jennifer L A Wilkinson-Berka, Robert Di Nicolantonio

Research output: Contribution to journalArticleResearchpeer-review

Abstract

1. Epidemiological studies indicate that a reduced birthweight increases the likelihood of human cardiovascular disease later in life. The role of hormonal factors in this finding is not known. Given that angiotensin II is believed to be a fetal regulator of growth, we have examined in the hypertensive Ren-2 transgenic rat whether it has active renin in its amniotic fluid and whether this is associated with fetal underdevelopment. 2. We found that while the Sprague-Dawley rat contained no active renin in its amniotic fluid near term (20 days), Ren-2 amniotic fluid contains high levels of active renin and is associated with a reduced fetal weight. 3. This is the first report of active renin in the rat and allows the possibility that renin overproduction plays a role in reduced fetal growth and the prenatal 'programming' of essential hypertension that has been proposed to occur in humans.

Original languageEnglish
Pages (from-to)631-633
Number of pages3
JournalClinical and Experimental Pharmacology and Physiology
Volume27
Issue number8
DOIs
Publication statusPublished - 2000
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Amniotic fluid
  • Fetus
  • Hypertension
  • Intra-uterine growth retardation
  • Pregnancy
  • Prorenin
  • Ren-2
  • Renin-angiotensin system

Cite this